Related Experiment Video
Updated: Jul 5, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Factors associated with osteonecrosis of the jaw among bisphosphonate users
Lisa M Hess1, Joanne M Jeter, Marge Benham-Hutchins
1College of Medicine, Arizona Cancer Center, University of Arizona, Tucson, AZ 85724-5024, USA. hess@u.arizona.edu
Background:
Bisphosphonates are medications that impact bone reformation by inhibiting osteoclast function. Osteonecrosis of the jaw has been reported among patients receiving these medications. It is unclear if the risk factors associated with osteonecrosis of the jaw among cancer patients taking bisphosphonates also are possible risk factors among patients receiving these medications for other indications.
Methods:
A systematic review search strategy was used to identify cases of osteonecrosis of the jaw among patients taking bisphosphonates for an indication other than cancer to identify potential contributing factors. Data were analyzed according to previous models to develop a more expanded model that may explain possible mechanisms for the development of osteonecrosis of the jaw among patients without cancer.
Results:
Ninety-nine cases of osteonecrosis of the jaw were identified among patients who were prescribed a bisphosphonate for an indication other than cancer. These cases included 85 osteoporosis patients, 10 patients with Paget's disease, 2 patients with rheumatoid arthritis, 1 patient with diabetes, and 1 patient with maxillary fibrous dysplasia. The mean age was 69.4 years, 87.3% were female, and 83.3% were receiving oral, but not intravenous, bisphosphonates. Of the 63 patients reporting dental care information, 88.9% had a dental procedure before the onset of osteonecrosis of the jaw. Of all cases providing medical information, 71% were taking at least one medication that affects bone turnover in addition to the bisphosphonate, and 81.3% reported additional underlying health conditions.
Conclusions:
The case details suggest a multiplicity of factors associated with this condition and provide the foundation for a model outlining the potential mechanism for the development of osteonecrosis of the jaw among patients taking bisphosphonates for an indication other than cancer.
Insights
Osteonecrosis of the jaw (ONJ) can occur in patients taking bisphosphonates for non-cancer reasons. Multiple factors, including dental procedures and other medications, contribute to ONJ risk in these patients.
Area of Science:
- Oral and Maxillofacial Surgery
- Pharmacology
- Bone Biology
Background:
- Bisphosphonates inhibit osteoclast function, impacting bone remodeling.
- Osteonecrosis of the jaw (ONJ) is a known complication associated with bisphosphonate therapy.
- Risk factors for ONJ in cancer patients on bisphosphonates may differ from those in non-cancer patients.
Purpose of the Study:
- To identify potential contributing factors for osteonecrosis of the jaw (ONJ) in patients using bisphosphonates for non-cancer indications.
- To develop an expanded model for understanding ONJ mechanisms in patients without a cancer diagnosis.
Main Methods:
- Systematic review of cases of ONJ in patients taking bisphosphonates for non-cancer reasons.
- Analysis of identified cases using established models to create a more comprehensive explanatory model.
Main Results:
- Ninety-nine cases of ONJ were identified in patients treated with bisphosphonates for non-cancer conditions (e.g., osteoporosis, Paget's disease).
- Most patients were older females on oral bisphosphonates, with a high incidence of prior dental procedures.
- A significant percentage of patients had concurrent medications affecting bone turnover and underlying health conditions.
Conclusions:
- The development of ONJ in patients on bisphosphonates for non-cancer indications is multifactorial.
- A proposed model outlines potential mechanisms for ONJ in this patient population.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
What is the Skeletal System?